Navigation Links
Boston College's Amir Hoveyda receives Italy's Eni Award for Hydrocarbons Research
Date:6/17/2014

Chestnut Hill, Mass. (June 17, 2014) Boston College Professor of Chemistry Amir Hoveyda has received a 2014 Eni Award for New Frontiers in Hydrocarbons from an international panel of preeminent scientists assembled by the Enrico Mattei Foundation of the Italian energy giant Eni SpA.

Hoveyda and other leading researchers were honored June 17 at a ceremony in Rome, hosted by Italian President Giorgio Napolitano in the official presidential palace, the historic Quirinale. Hoveyda received a gold medal struck at the Italian State Mint and a cash award of $270,000 (US). The Eni Awards recognize leading researchers in the areas of energy and sustainable chemistry, part of an effort to promote innovation in energy use and research by Eni, which employs 82,300 people in 85 countries.

"I am humbled," said Hoveyda, the Joseph T. and Patricia Vanderslice Millennium Professor of Chemistry and a 24-year faculty member at BC. "This is further testimony to the dedication, creativity and industriousness of more 100 selfless doctoral, post-doctoral and undergraduate scholars who have asked and addressed scientific questions in my laboratories since 1990 at Merkert Chemistry Center. This is first and foremost applause for their accomplishments."

Hoveyda was honored in the "downstream" category for transformations of hydrocarbons drawn from raw materials. Hoveyda develops new catalysts for chemical synthesis that are sustainable, easy and cost-effective to access, and able to generate valuable products of exceptional purity with high efficiency - characteristics critical to advances in the life sciences and medicine.

Hoveyda joins an illustrious group of scientists who have receive the Eni, including Nobel laureate Sir Harold Kroto of the University of Sussex, and US researchers including MIT's Gregory Stephanopoulos, U.C. Berkeley's Enrique Iglesia, Cal Tech's Frances H. Arnold and Craig Venter of the Institute for Genomic Research.

The 2014 Eni Scientific Award Commission cited Hoveyda's development of catalysts capable of synthesizing complex molecules with unique steric properties, or specifically distinct spatial arrangements of their main chain atoms. Hoveyda catalysts produce high purity compounds used in pharmaceuticals, fine chemicals and agrochemicals, with applications that extend into advanced materials and polymers. Some of the catalysts are being used in large-scale preparation of hydrocarbon-based therapeutics.

The connections to energy lie in the development of exceptionally efficient catalysts with high turnover ratios in a short amount of time, involving the use of non-precious and abundant elements that convert readily available renewable materials into highly valued molecules humans rely upon.

"Such catalysts do not demand heating or cooling, or the energy required to promote such reactions," Hoveyda said. "They do not require expending our non-renewable resources, which demand substantial time and energy to mine, and generate minimal amounts of environmentally harmful waste and reduce the energy costs of disposal. Catalysts and catalytic chemical reactions that depend on renewable resources and abundant elements are, without a doubt, a critical part of our future."

Sobell Professor of Chemistry Ilan Marek, of the Technion Israel Institute of Technology, said Hoveyda's work has had far-reaching implications within the field of hydrocarbons.

"I would be hard pressed to identify another individual whose contributions to the field of catalysis involving carbon-carbon bonds match Amir's in terms of quality and quantity," said Marek. "Throughout his career, Amir's work has been characterized by remarkable originality and far-sightedness. He has been a central figure in the definition of major fields as we known them asymmetric catalysis, metathesis, and carbenes to name a few. In each case, the field was revolutionized by his work."

Hoveyda has been ranked among the world's Top 100 Chemists by Thomson Reuters. Among his honors are the 2014 American Chemical Society Award for Creative Work in Synthetic Organic Chemistry, the 2010 Yamada-Koga Prize from the Chemical Society of Japan and a 2005 National Institutes of Health MERIT Award, an honorific 10-year grant. He is co-founder of the life sciences firm XiMo AG, which commercializes catalysts discovered in the Hoveyda lab.

Hoveyda said his work supports other scientists, and ultimately serves patients treated with new therapeutics, and is intended to provide some measure of relief for an already overburdened planet.

"My hope is that our catalysts, many of which are already widely used all over the world in academic as well as industrial labs, will play a meaningful role in lowering suffering and pain, will help protect this beautiful planet that has been so badly abused by us humans," Hoveyda said. "I hope that our catalysts and methods of performing new chemical reactions will improve the quality of life for all living creatures without endangering our magnificent planet or having to mortgage the happiness of the future generations."


'/>"/>

Contact: Ed Hayward
ed.hayward@bc.edu
617-552-4826
Boston College
Source:Eurekalert  

Related biology news :

1. Boston Police Chief to Address Boston Marathon Bombings at IEEE Homeland Security Conference in Waltham, Mass., on 12 November
2. New findings on tree nuts and health presented at the Experimental Biology Meeting in Boston, Mass.
3. NIH grant funds Boston College research into illnesses afflicting people living with HIV
4. Michael Barnett of Boston College named Professor of the Year for Massachusetts
5. Synthetic biofilter wins through to the top Sweet 16 in Boston
6. Boston subway system to be used to test new sensors for biological agents
7. BUSM/VA Boston Healthcare System investigators identify new gene linked to PTSD
8. Boston Healthcare Associates Roundtable Explores Challenges and Opportunities Surrounding the Value of Big Data within the Life Sciences
9. Attendees Save Up To $800 on Boston-area Pharmaceutical and Healthcare Conferences, Early Bird Discounts Expiring April 27
10. Annual Drug Discovery Conferences Being Held in Boston MA, Spring 2012
11. Partnership enhances biology teaching at California community colleges
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Boston College's Amir Hoveyda receives Italy's Eni Award for Hydrocarbons Research
(Date:6/2/2016)... , June 2, 2016 The Department ... has awarded the 44 million US Dollar project, for the ... Vehicle Plates including Personalization, Enrolment, and IT Infrastructure , ... in the production and implementation of Identity Management Solutions. Numerous ... however Decatur was selected for the ...
(Date:6/2/2016)... , June 2, 2016 Perimeter ... Platforms, Unmanned Systems, Physical Infrastructure, Support & Other Service  ... visiongain offers comprehensive analysis of the global ... market will generate revenues of $17.98 billion in 2016. ... DVTEL Inc, a leader in software and hardware technologies ...
(Date:5/24/2016)... facilitates superior patient care by providing unparalleled technology to leaders of the medical imaging ... product recently added to the range of products distributed by Ampronix. Photo ... ... ... News ...
Breaking Biology News(10 mins):
(Date:6/23/2016)... , June 23, 2016   Boston Biomedical ... novel compounds designed to target cancer stemness pathways, ... been granted Orphan Drug Designation from the U.S. ... of gastric cancer, including gastroesophageal junction (GEJ) cancer. ... designed to inhibit cancer stemness pathways by targeting ...
(Date:6/23/2016)... 2016  The Prostate Cancer Foundation (PCF) is pleased to announce ... cures for prostate cancer. Members of the Class of 2016 were selected from ... Read More About the Class of 2016 PCF Young Investigators ... ... ...
(Date:6/23/2016)... Durham, NC (PRWEB) , ... June 23, 2016 , ... ... Odense University Hospital in Denmark detail how a patient who developed lymphedema after being ... (fat) tissue. The results could change the paradigm for dealing with this debilitating, frequent ...
(Date:6/23/2016)... ... 23, 2016 , ... ClinCapture, the only free validated electronic ... showcase its product’s latest features from June 26 to June 30, 2016 for ... Disrupting Clinical Trials in The Cloud during the conference. DIA (Drug Information ...
Breaking Biology Technology: